R. Jayachandra Babu
Title
Cited by
Cited by
Year
Nanomedicine scale-up technologies: feasibilities and challenges
R Paliwal, RJ Babu, S Palakurthi
Aaps Pharmscitech 15 (6), 1527-1534, 2014
1322014
Amorphous-state characterization of efavirenz—polymer hot-melt extrusion systems for dissolution enhancement
SK Sathigari, VK Radhakrishnan, VA Davis, DL Parsons, RJ Babu
Journal of pharmaceutical sciences 101 (9), 3456-3464, 2012
1102012
Physicochemical characterization of efavirenz–cyclodextrin inclusion complexes
S Sathigari, G Chadha, YHP Lee, N Wright, DL Parsons, VK Rangari, ...
Aaps Pharmscitech 10 (1), 81-87, 2009
992009
In vitro and in vivo evaluation of topical formulations of spantide II
L Kikwai, RJ Babu, R Prado, A Kolot, CA Armstrong, JC Ansel, M Singh
Aaps Pharmscitech 6 (4), E565-E572, 2005
842005
Formulation of controlled release gellan gum macro beads of amoxicillin
RJ Babu, S Sathigari, MT Kumar, JK Pandit
Current drug delivery 7 (1), 36-43, 2010
822010
Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin
RJ Babu, JK Pandit
International journal of pharmaceutics 271 (1-2), 155-165, 2004
802004
Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems
RJ Babu, JK Pandit
International journal of pharmaceutics 288 (2), 325-334, 2005
772005
Formulation and in vitro evaluation of transdermal patches of melatonin
N Kanikkannan, S Andega, S Burton, RJ Babu, M Singh
Drug development and industrial pharmacy 30 (2), 205-212, 2004
752004
Role of cyclodextrins in nanoparticle-based drug delivery systems
H Shelley, RJ Babu
Journal of pharmaceutical sciences 107 (7), 1741-1753, 2018
722018
Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size …
P Dayal, V Pillay, RJ Babu, M Singh
Aaps Pharmscitech 6 (4), E573-E585, 2005
702005
Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro
L Kikwai, N Kanikkannan, RJ Babu, M Singh
Journal of controlled release 83 (2), 307-311, 2002
622002
Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin
RJ Babu, JK Pandit
Drug delivery 12 (3), 165-169, 2005
492005
The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide
RJ Babu, N Kanikkannan, L Kikwai, C Ortega, S Andega, K Ball, S Yim, ...
Journal of controlled release 86 (1), 49-57, 2003
462003
Lipid materials for topical and transdermal delivery of nanoemulsions
KR Pawar, RJ Babu
Critical Reviews™ in Therapeutic Drug Carrier Systems 31 (5), 2014
392014
Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement
GP Sanganwar, S Sathigari, RJ Babu, RB Gupta
European Journal of Pharmaceutical Sciences 39 (1-3), 164-174, 2010
392010
Effect of cyclodextrins on the complexation and nasal permeation of melatonin
RJ Babu, P Dayal, M Singh
Drug delivery 15 (6), 381-388, 2008
372008
Gefitinib–cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies
YH Phillip Lee, S Sathigari, YJ Jean Lin, WR Ravis, G Chadha, ...
Drug development and industrial pharmacy 35 (9), 1113-1120, 2009
362009
Glass transitions in binary drug+ polymer systems
RJ Babu, W Brostow, IM Kalogeras, S Sathigari
Materials Letters 63 (30), 2666-2668, 2009
352009
Estimation of proinflammatory biomarkers of skin irritation by dermal microdialysis following exposure with irritant chemicals
SV Fulzele, RJ Babu, E Ahaghotu, M Singh
Toxicology 237 (1-3), 77-88, 2007
342007
Assessment of skin irritation and molecular responses in rat skin exposed to nonane, dodecane and tetradecane
RJ Babu, A Chatterjee, M Singh
Toxicology letters 153 (2), 255-266, 2004
322004
The system can't perform the operation now. Try again later.
Articles 1–20